SCHEMBL15079917

SCHEMBL15079917

Cc1ccccc1OCC(O)c1ccccc1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.57
CYP1A2 P05177 2/20 0.57
ALOX15 P16050 1/20 0.53
LMNA P02545 5/20 0.50
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ADRB2 P07550 1/20 0.50
ADRB1 P08588 1/20 0.50
ADRB3 P13945 1/20 0.50
SCN4A P35499 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
NPY1R P25929 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15079623 0.84 LMNA (0.57) KDM4ECYP1A2ALOX15LMNASMN1; SMN2
SCHEMBL15079863 0.81 KMT2A (0.43) KDM4EALOX15LMNAKMT2AMEN1
SCHEMBL1496780 0.78 SCN4A (0.65) KDM4ECYP1A2ALOX15LMNAKMT2A
SCHEMBL7120229 0.77 KDM4E (0.70) KDM4ECYP1A2ALOX15LMNAKMT2A
SCHEMBL18423672 0.77 KDM4E (0.82) KDM4ECYP1A2ALOX15LMNAKMT2A
SCHEMBL3629149 0.75 KDM4E (0.68) KDM4ECYP1A2ALOX15LMNAKMT2A
SCHEMBL15079364 0.75 MEN1 (0.47) KDM4ELMNAKMT2AMEN1SMN1; SMN2
SCHEMBL9854787 0.74 CYP1A2 (0.41) CYP1A2LMNAKMT2AMEN1SMN1; SMN2
SCHEMBL15079914 0.74 TSHR (0.46) KDM4ELMNAKMT2AMEN1SMN1; SMN2
SCHEMBL11104803 0.74 KDM4E (0.66) KDM4ECYP1A2ALOX15LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2015-01-01 US disclosed
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2015-01-01 US disclosed
WO-2013093320-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS DIVERCHIM (FR) 2013-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150004110-A1 NOVEL ANTI-AGING AND DEPIGMENTING COSMETIC COMPOSITIONS ARG1, TYR, NOS1 KDM4E 598/4885CYP1A2 828/4885ALOX15 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.